LYTIX fundamentals
An in-depth look to LYTIX BIOPHARMA AS operating, investing, and financing activities
LYTIX free cash flow for Q2 24 is -12.73 M NOK. For 2023, LYTIX free cash flow was -93.67 M NOK and operating cash flow was -93.62 M NOK.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: NOK
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM